RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
Feb 2011 - 26 pages - $5,700
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010
Dec 2010 - 48 pages - $1,000
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow
May 2011 - 6 pages - $500
Stakeholder Opinions: Respiratory viral infections - Respiratory syncytial virus, parainfluenza virus and human metapneumovirus as promising new targets
Apr 2010 - 139 pages - $3,800
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
West Nile Virus Infections - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
West Nile Virus Infections - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Herpes Simplex Virus Infection Therapy Area Pipeline Report
Nov 2010 - 245 pages - $1,495
More Related Market Research Reports >>>

Your selection

Industry sector
Research tools del
Mouse models del
Therapeutic target
Infectious diseases del
Bacteria or virus del
Parainfluenza virus (Type 3) del
Geographic location
North America del
Canada del
Newfoundland del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us